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Edited by Berend WieringaAbstract Autophagy depends on the activity of phosphoinosi-
tide-3 kinase class III to generate PI(3)P. We identiﬁed the hu-
man WIPI protein family of PI(3)P-binding factors and showed
that WIPI-1 (Atg18) is linked to autophagy in human cells.
Induction of autophagy by rapamycin, gleevec, thapsigargin
and amino acid deprivation led to an accumulation of WIPI-1
at LC3-positive membrane structures (WIPI-1 puncta-forma-
tion), suggested to represent autophagosomal isolation mem-
branes. WIPI-1 puncta-formation is inhibited by wortmannin
and LY294002, and PI(3)P-binding-deﬁcient WIPI-1 is punc-
ta-formation-incompetent. Quantiﬁcation of WIPI-1 puncta
should be suitable to assay mammalian autophagy.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Macroautophagy (=autophagy) is an intracellular bulk deg-
radation mechanism constitutively active to regulate the turn-
over of long-lived proteins and organelles [1]. In response to
starvation or cellular insults, autophagic activity is drastically
elevated to secure cellular survival [2]. For engulfment and
digestion of cargo, autophagosomes are formed and fuse with
lysosomes [3]. Induction of autophagosome formation requires
phospatidylinositiol-3-phosphate (PI(3)P), isolation mem-
branes of unknown origin [4], and two ubiquitin-like conjuga-
tion systems. The Atg5/Atg12/Atg16 complex is a phagophore
marker [5–7]. Membrane-binding competent LC3 protein is
conjugated to phosphatidyl ethanolamine (LC3-II) [8,9] and
unconjugated LC3 (LC3-I) is distributed throughout the cell.
Both visualization of GFP-LC3-II accumulation at autophag-
osomal membranes (GFP-LC3 puncta-formation) and ratio
change detection of LC3-I/LC3-II have been employed to
monitor mammalian autophagy [10].Abbreviations: WIPI, WD-repeat protein interacting with phosphoin-
ositides; PI(3)P, phosphatidylinositol-3-phosphate; EM, electron
microscopy
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doi:10.1016/j.febslet.2007.06.040Previously, we identiﬁed the human WD-repeat protein
interacting with phosphoinositides (WIPI) protein family and
showed that WIPI-1 is linked to autophagy in human tumor
cells [11]. This ﬁnding was consistent with the WIPI-1 ortho-
logue Atg18 in S. cerevisiae and A. thaliana [12–14] to function
in autophagy.
Here we provide evidence that the quantiﬁcation of WIPI-1
protein accumulation (WIPI-1 puncta-formation) represents a
new monitoring opportunity for mammalian autophagy.2. Materials and methods
2.1. cDNA constructs
GFP-5d1d (in pEGFPÆC1) was generated by PCR cloning using GFP-
WIPI-1 cDNA [11] and oligonucleotides that substituted nucleotides
N661–684 by those of N145–162: 5 0agagagaagcttttgcccatcagggacaga-
gaacac-3 0; 5 0-agagagaagcttgatcaagtccacggaagcatgaaaaggtatg-tgacaat-
cagctctctagtg-30. pAR31CD-WIPI-1a [11] was used to generate
myc-tagged WIPI-1 (in pCMV-Tag3A) by PCR cloning (oligonucleo-
tides: 5 0-gagagagaattaagaggccgaggccgcggacgct-30; 5 0-gagagactcgag-
tcatgactgcttcgttttgcc-3 0).
2.2. Cell culture and transient transfections
G361, HeLa and U2OS cells (ATCC) were cultured in DMEM, 10%
FCS, 100 U/ml penicillin, 100 lg/ml streptomycin at 37 C, 5% CO2.
Transient transfections [11] included empty vector controls (not
shown).
2.3. Autophagy assays
Autophagy was induced by rapamycin treatment (100–300 nM) or
by amino acid deprivation (EBSS) for 3 h (37 C, 5% CO2) in the pres-
ence or absence of wortmannin (233 nM) [11]. LY294002, gleevec (Tim
Brummendorf, Hamburg), thapsigargin were used at 100 lM, 10 lM,
100 nM, respectively.
2.4. Confocal microscopy
According to [11] confocal microscopy was used: Zeiss Axiovert
100M/LSM510 and a 63 · 1.4 DIC Plan-Apochromat oil-immersion
objective [11]. Antibodies: anti-WIPI-1 [11], anti-myc (9E10) (Santa
Cruz), anti-rabbit IgG Alexa Fluor 488, anti-mouse IgG Alexa Fluor
546 (Molecular Probes). Dyes: TO-PRO-3 (Molecular Probes).
2.5. Quantiﬁcation of WIPI-1 puncta-formation
For quantitative confocal microscopy of endogenous WIPI-1 or
overexpressed GFP-WIPI-1, 1–6 slides (1–3 · 100 cells/slide) were ana-
lyzed (each assay condition), and results presented as percentage of
cells displaying WIPI-1 puncta versus cells displaying distributed
WIPI-1 (±S.D.). Using Image-Pro plus 4.5 (MediaCybernetics) confo-
cal images of LC3-GFP puncta were used to determine the mean inten-
sity of LC3 puncta per cell (±S.D.).ation of European Biochemical Societies.
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According to [15] ultrathin cryosections were obtained using a Leica
Ultracut UCT/EM FCS cryoultramicrotome at 105 C and labelled
with anti-WIPI antiserum or anti-GFP antibodies (1:250; Abcam)
and silver-enhanced (HQ Silver, 8 min; Nanoprobes, USA) IgGNano-
gold (1:60; Nanoprobes) (LEO 906 transmission electron microscope).
2.7. Phospholipid–protein overlay assay
G361 cell extracts (750 mM aminocraproic acid, 50 mM Bis–Tris,
0.5 mM EDTA, pH 7.0, Protease Inhibitor Cocktail) were used to
overlay membrane-immobilized phospholipid membranes (Molecular
Probes). ECL detection of bound WIPI protein (anti-WIPI antiserum
or anti-GFP antibody/Roche Applied Sciences) was quantiﬁed (Image-
Quant 5.1) and normalized over protein expression levels.3. Results
3.1. Induction of autophagy and WIPI-1 puncta-formation
correlates with elevated levels of autophagosomal LC3-II
Using sub-conﬂuent human G361 cells, autophagy was
induced by rapamycin administration or by amino acidFig. 1. Endogenous WIPI-1 puncta-formation correlates with autophagy in h
in the presence or absence of wortmannin (WM). WIPI-1 puncta-formation w
IgG Alexa 488) and confocal microscopy (bars 10 lm) (a). Results from a
quantiﬁed (b) and the ratios of cells in puncta/non-puncta status determined (
by anti-LC3 ECL and LC3-II/LC3-I ratios were determined (d) Anti-GAPDdeprivation (EBSS) and inhibited by wortmannin. Visualiza-
tion of endogenous WIPI-1 by confocal microscopy demon-
strated that mock treated G361 cells predominantly
displayed a diﬀuse cytoplasmic distribution of WIPI-1
(Fig. 1a, upper). In contrast, upon rapamycin administration
WIPI-1 protein predominantly accumulated to vesicular and
tubular structures (WIPI-1 puncta-formation) (Fig. 1a).
WIPI-1 puncta-formation was quantiﬁed and expressed as
percentage of cells displaying distinct WIPI-1 protein accu-
mulations (puncta) versus cells displaying a diﬀuse cytoplas-
mic distribution of WIPI-1 (non-puncta) (Fig. 1b, Supple-
mentary Table 1).
This quantiﬁcation demonstrated that an average of 70%
unstimulated G361 cells (mock) displayed cytoplasmic WIPI-
1 protein distribution (non-puncta) and 30% displayed WIPI-
1 accumulations (puncta). Wortmannin administration led to
a drastic reduction in WIPI-1 puncta-formation (6%). Strik-
ingly, induction of autophagy was reﬂected by an increase in
the total cell number displaying WIPI-1 puncta, i.e. 86%
and 75% after rapamycin and EBSS treatment, respectively.uman G361 cells. Autophagy was induced by rapamycin (R) or EBSS
as detected by immunoﬂuorescence (anti-WIPI-1 antiserum/anti-rabbit
total of 900 cells per treatment (six independent experiments) were
c) (Supplementary Table 1). In parallel, LC3-I and LC3-II was detected
H ECL was conducted to control equal loading (c).
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(Fig. 1b).
In the above experiments (four independent sets) we moni-
tored non-autophagosomal LC3-I and autophagosomal LC3-
II by Western blotting (Fig. 1d). We determined the LC3-II/Fig. 2. GFP-WIPI-1 puncta-formation correlates with autophagy in human
GFP-WIPI-1 puncta-formation was expressed as puncta/non-puncta ratio (e
Bars 20 lm.LC3-I ratio as a measure for the induction or inhibition of
autophagy (Fig. 1c, Supplementary Table 2). The increase of
LC3-II/LC3-I upon induction of autophagy strongly corre-
lated with endogenous WIPI-1 puncta-formation, expressed
as WIPI-1 puncta/non-puncta ratio (Fig. 1c).G361 (a and b), HeLa (c) and U2OS (d) cells (Supplementary Table 3).
) and fold increase of ratio upon rapamycin treatment (over mock) (f).
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human cell lines
We quantiﬁed puncta-formation employing transiently ex-
pressed GFP-WIPI-1 in G361, HeLa and U2OS cells upon
rapamycin, wortmannin or rapamycin/wortmannin adminis-Fig. 3. LC3-GFP puncta analysis in transfected G361, HeLa and U2OS cells
LC3-GFP puncta number per cell (mean ﬂuorescent intensities) was deter
Wortmannin administration resulted in non-puncta-formation of myc-WI
(confocal microscopy using anti-myc(9E10)/Alexa 546) (c). Bars 10 lm.tration (Fig. 2, Supplementary Table 3). Representative images
are shown for G361 cells (Fig. 2a). When comparing mock-
treatment versus autophagy stimulation, more cells displayed
WIPI-1 puncta upon rapamycin treatment, and – conversely
– more cells displayed distributed WIPI-1 protein (non-puncta). Comparison of GFP-WIPI-1 and LC3-GFP puncta in G361 cells (a).
mined in G361, HeLa and U2OS cells (b, Supplementary Table 5).
PI-1 but LC3-GFP remained punctated in coexpressing HeLa cells
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further expressed as WIPI-1 puncta/non-puncta ratios (Fig. 2e)
demonstrating striking ratio increases of 16-, 8- and 7-fold
(over mock) in G361, HeLa, U2OS cells, respectively, upon
the induction of autophagy (Fig. 2f).
Equivalents of the above experiments used transfected LC3-
GFP. Here distinction between puncta and non-puncta was
not possible since – qualitatively – all transfected cells
(G361, HeLa, U2OS) showed LC3-GFP puncta in mock trea-Fig. 4. GFP-WIPI-1 puncta-formation upon treatments (3 or 24 h) of HeLa c
Table 6). Inhibition of autophagy by wortmannin and LY294002 (d, e, Supted as well as rapamycin, wortmannin, rapamycin/wortmannin
treated cells (Fig. 3a, Supplementary Table 4). Next, we quan-
tiﬁed the numbers of LC3-puncta (mean ﬂuorescent intensities)
per cell. We observed an increase of LC3-GFP puncta per cell
upon rapamycin treatment, and a decrease upon the inhibition
of autophagy (wortmannin treatment) in G361, HeLa and
U2OS cells (Fig. 3b, Supplementary Table 5).
Using myc-WIPI-1/LC3-GFP coexpressing cells, LC3-GFP
kept a punctate status at conditions of autophagy inhibition,ells with rapamycin, EBSS, Gleevec, Thapsigargin (a–c, Supplementary
plementary Table 7). Bars 10 lm.
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localization (non-puncta) (Fig. 3c).
3.3. GFP-WIPI-1 puncta-formation assay investigating diﬀerent
autophagy modulating agents
Induction of autophagy by prominent inducers such as rap-
amycin, amino acid deprivation, gleevec [16] and thapsigargin
[17] was apparent employing the GFP-WIPI-1 puncta-forma-
tion assay in HeLa cells (Fig. 4a). WIPI-1 puncta/non-puncta
ratios increased upon 3 h (Fig. 4b) and more prominently upon
24 h treatments (Fig. 4c). Amino acid starvation led to the
strongest induction of autophagy in transiently transfected
HeLa cells (Fig. 4b,c). Similarly, inhibition of autophagy byFig. 5. P colocalization of Myc-WIPI-1 and LC3-GFP upon rapamycin-ind
coexpressed in U2OS (a) and G361 (b) cells, and autophagy induced by rapam
antibody/anti-mouse IgG Alexa 546) and LC3-GFP was apparent by m
endogenous WIPI-1 (c–e) and GFP-WIPI-1 (f, g) at multi-membrane structur
treated G361 cells (f: magniﬁcation of g) (Bars: 100 nm).the inhibitors wortmannin and LY294002 peptide [18] corre-
lated with reduced scores in GFP-WIPI-1 puncta-formation
(G361 cells, Fig. 4d, e).3.4. Myc-tagged WIPI-1 colocalizes with LC3-GFP
Previously, we demonstrated that accumulated endogenous
WIPI-1 partially colocalized with accumulated LC3-GFP in
human G361 cells [11]. Here, we coexpressed myc-tagged
WIPI-1 and LC3-GFP in U2OS (Fig. 5a), G361 (Fig. 5b)
and HeLa cells (not shown) and conﬁrmed a prominent
WIPI-1/LC3 colocalization at LC3-GFP marked autophago-
somal membranes.uced autophagy. Myc-tagged WIPI-1 and LC3-GFP were transiently
ycin treatment. Colocalization of Myc-tagged WIPI-1 (anti-myc(9E10)
erging the confocal microscopy images. Bars: 10 lm. Detection of
es by immunogold localization on ultrathin cryosections of rapamycin-
3402 T. Proikas-Cezanne et al. / FEBS Letters 581 (2007) 3396–34043.5. Endogenous WIPI-1 and transfected GFP-WIPI-1 localize
at multi-membrane structures upon the induction of
autophagy
We localized endogenous WIPI-1 or transiently expressed
GFP-WIPI-1 in autophaging human G361 cells (rapamycin
treatment) by immunogold staining on ultrathin cryosections,PI(3,5)P2
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incompetent mutant is puncta-formation-incompetent (d, bars 10 lm): a quarespectively using anti-WIPI-1 antiserum (Fig. 5c–e) or anti-
GFP antibodies (Fig. 5f–g). Strikingly, we found that
WIPI-1 localized to multi-membrane structures that closely
resemble autophagosomal cup-shaped isolation membranes
[19]. So far, we were unable to detect WIPI-1 at complete auto-
phagosomes.2 43 75 6 6
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We conducted phospholipid–protein overlay assays and
demonstrate that human WIPI-1 speciﬁcally binds PI(3)P
and PI(3,5)P2, however, PI(3)P-binding occurred more promi-
nently (Fig. 6a). In order to generate a phosphoinositide bind-
ing-deﬁcient WIPI-1 mutant (GFP-5d1d) that should keep the
requirements for propeller folding, we deleted the FRRG mo-
tif [19,20] by substituting the corresponding beta-sheet 5d [11]
with a duplicate of beta-sheet 1d lacking the FRRG motif
(Fig. 6c). The GFP-5d1d mutant showed reduced PI(3)P-bind-
ing (14.23%; Fig. 6b) and was completely puncta-formation-
incompetent (Fig. 6d), demonstrated by quantitative confocal
microscopy (Fig. 6e, Supplementary Table 8).4. Discussion
There is an urgent need for new markers to monitor mam-
malian autophagy. Recently, diﬃculties in using LC3-GFP as
a marker for autophagy were noticed [21]. LC3-GFP protein
was reported to aggregate, thereby not reﬂecting autophagos-
omal structures. We also report here LC3-GFP to localize to
punctate structures independent of the cellular autophagic
state (Fig. 3a). However, we observed the number of LC3-
puncta per cell to increase during induction of autophagy,
and to decrease during inhibition of autophagy (Fig. 3b).
Such measurements were already employed by a variety of
studies e.g. [22]. In contrast, WIPI-1 puncta numbers do
not change within individual cells (not shown), but the overall
number of cells that displayed WIPI-1 puncta increased upon
induction and decreased upon inhibition of autophagy. These
changes in cellular WIPI-1 puncta ratios correlated tightly
with (i) overall LC3-II/LC3-I ratio changes (Fig. 1c), (ii)
changes in LC3-GFP puncta numbers per cell (Fig. 3b),
and (iii) accumulated autolysosomal MDC ﬂuorescence (not
shown) [23]. We demonstrated that known inducers of
autophagy, such as amino acid deprivation, rapamycin, glee-
vec and thapsigargin (as well as serum starvation or tamoxi-
fen administration (not shown)) led to an increase in GFP-
WIPI-1 puncta. Wortmannin and LY294002, inhibitors of
autophagy, nulliﬁed WIPI-1 puncta-formation. Both endoge-
nous WIPI-1 [11] and myc-WIPI-1 partially colocalized with
LC3-GFP at cup-shaped and vesicular structures upon the
induction of autophagy. Importantly, by IEM we demon-
strated that WIPI-1 localized to multi-membrane structures
of autophagic cells. These multi-membrane structures closely
resembled autophagosomal isolation membranes [19]. So far
we were unable to detect WIPI-1 at completed autophago-
somes (not shown). This may imply that WIPI-1 localizes
to pre-autophagosomal membranes and that occupied pre-
autophagosomal membranes represent WIPI-1 puncta, as
visualized by confocal microscopy. Autophagosomal mem-
brane association of WIPI-1 is further suggested by WIPI-1
speciﬁcally binding PI(3)P and binding-incompetent WIPI-1
being unable to accumulate to punctate structures upon
autophagy induction.
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